Literature DB >> 12794813

Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard?

Maarten Boers1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794813     DOI: 10.1002/art.11141

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  8 in total

Review 1.  Combination treatment strategies in early rheumatoid arthritis.

Authors:  E Suresh; C M Lambert
Journal:  Ann Rheum Dis       Date:  2005-04-28       Impact factor: 19.103

Review 2.  Potential of Oxytocin in the Treatment of Schizophrenia.

Authors:  Paul D Shilling; David Feifel
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

Review 3.  Limits of add-on trials: antirheumatic drugs.

Authors:  Laura Ottolenghi; Vittorio Bertele'; Silvio Garattini
Journal:  Eur J Clin Pharmacol       Date:  2008-09-03       Impact factor: 2.953

Review 4.  A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.

Authors:  David Feifel; Paul D Shilling; Kai MacDonald
Journal:  Biol Psychiatry       Date:  2015-08-13       Impact factor: 13.382

5.  Translational Research in Oncology: Implications for Palliative Care.

Authors:  Arunangshu Ghoshal
Journal:  Indian J Palliat Care       Date:  2017 Oct-Dec

6.  Early phase and adaptive design clinical trials in rheumatoid arthritis: a systematic review of early phase trials.

Authors:  Tim Pickles; Robin Christensen; Lai-Shan Tam; Lee S Simon; Ernest H Choy
Journal:  Rheumatol Adv Pract       Date:  2018-10-17

7.  Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial.

Authors:  T Pincus; C J Swearingen; G Luta; T Sokka
Journal:  Ann Rheum Dis       Date:  2008-12-15       Impact factor: 19.103

Review 8.  Randomized controlled trial design in rheumatoid arthritis: the past decade.

Authors:  Vibeke Strand; Jeremy Sokolove
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.